The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s porcine vaccine market report forecasts the porcine vaccine market size to grow to $2.34 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Porcine Vaccine Market Report 2023 – https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Porcine Vaccine Market Size Forecast
The global porcine vaccine market is expected to grow from $1.59 billion in 2022 to $1.74 billion in 2023 at a compound annual growth rate (CAGR) of 9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global porcine vaccine market size is expected to grow to $2.34 billion in 2027 at a CAGR of 7.8%.

North America held the largest porcine vaccine market share.

Key Porcine Vaccine Market Driver ­– Increase In The Infection Of Swine Disease
According to a report published in December 2021 by the Swine Health Information Centre, a US-based organisation that protects and improves swine health, European countries recorded 1,844 outbreaks of African Swine Fever (ASF) in domestic pigs in the year 2021. As a result, growing swine disease infection is boosting the porcine vaccination market.

Request for A Sample Of The Global Porcine Vaccine Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

Key Porcine Vaccine Market Trend – Product Innovations
To strengthen their market position, major market players are focusing on developing novel goods. For example, in March 2021, Boehringer Ingelheim, a German vaccine manufacturer, will launch ParvoPRRS®. It offers more litters and better breeding herds by improving reproductive health and output. The novel combination vaccine is safe for use during all phases of lactation and pregnancy, and it complements mass vaccination methods in breeding herds.

Porcine Vaccine Market Segment
1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines
2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications
3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

Porcine Vaccine Market Major Players and Strategies
Major players in the porcine vaccine market are Bayer AG, Bimeda Holdings PLC, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck Animal Health, Sanofi Pasteur Inc., Vetoquinol, Zoetis Animal Health, HIPRA, Elanco Animal Health Incorporated, Arko Laboratories Ltd., PBS Animal Health, Aptimmune Biologics Inc., Merial Animal Health, DT Biologika GmbH, and Intervet Inc.

Vaxxinova International BV, a Dutch company that makes and supplies animal health products such as vaccines, diagnostics, and feed additives, bought Newport Labs from Boehringer Ingelheim for an unknown sum in October 2021. Vaxxinova International BV intends to use this acquisition to build a strategy to grow and improve its products and services for livestock farmers and veterinarians in order to expand its footprint in cattle and swine illness. Newport Labs is a laboratory in the United States that specialises in custom-made vaccines for pigs and cattle.

The Porcine Vaccine Global Market Report 2023 covers regional data on porcine vaccine market size, porcine vaccine market trends and drivers, opportunities, strategies, and porcine vaccine market competitor analysis. The countries covered in the porcine vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Porcine vaccinations are a medical and pharmaceutical treatment that improves pig health by protecting them against various bacteria, viruses, and diseases. It is used to improve the effectiveness of protecting pigs from hazardous diseases while improving the yield of high-quality meat for human consumption.

View More Reports Related To The Porcine Vaccine Market –
Adult Vaccines Global Market Report 2023
Pediatric Vaccine Global Market Report 2023
Nanomaterials Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: